Chemocentryx, inc. (CCXI)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Revenue:
Collaboration and license revenue from related party

33,480

35,952

35,413

33,807

41,656

42,875

0

0

0

-

-

-

0

-

0

0

-

-

-

-

0

-

-

-

4,133

6,060

7,480

7,086

6,328

5,419

29,326

29,639

29,743

31,673

0

0

0

Grant revenue

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

33,809

36,128

35,413

33,807

41,656

42,875

89,844

89,898

83,813

82,497

30,327

23,918

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Research and development

74,233

70,276

66,174

63,213

63,348

62,736

60,517

57,697

54,267

49,495

45,863

41,937

36,670

37,945

36,926

36,468

36,008

33,183

34,074

33,686

34,086

33,815

32,111

32,761

32,435

33,541

35,344

35,897

36,915

34,569

30,794

30,369

27,948

28,359

0

0

0

General and administrative

27,474

24,155

22,815

22,072

21,250

20,409

18,909

17,160

16,596

16,509

15,937

15,506

15,199

14,710

14,584

15,202

14,901

14,506

14,245

13,944

13,750

13,584

13,394

12,766

12,193

11,634

11,481

11,218

10,882

10,480

9,548

8,701

8,169

7,615

0

0

0

Total operating expenses

101,707

94,431

88,989

85,285

84,598

83,145

79,426

74,857

70,863

66,004

61,800

57,443

51,869

52,655

51,510

51,670

50,909

47,689

48,319

47,630

47,836

47,399

45,505

45,527

44,628

45,175

46,825

47,115

47,797

45,049

40,342

39,070

36,117

35,974

0

0

0

Loss from operations

-67,898

-58,303

-53,576

-51,478

-42,942

-40,270

10,418

15,041

12,950

16,493

-30,715

-31,136

-31,704

-40,720

-44,464

-48,875

-50,909

-47,689

-48,319

-47,630

-47,836

-47,399

-44,780

-43,280

-40,495

-39,115

-39,345

-40,029

-41,469

-39,630

-11,016

-9,431

-6,374

-4,301

0

0

0

Other income (expense):
Interest income

4,826

4,963

4,907

4,662

4,036

3,528

2,838

2,122

1,666

1,370

1,254

1,163

988

757

592

428

367

384

401

422

451

494

532

550

531

501

482

489

546

533

494

448

386

402

0

0

0

Interest expense

2,155

2,149

2,077

1,958

1,592

1,224

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

24

34

44

53

59

64

70

76

794

1,340

1,437

1,442

734

0

0

0

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Total other income, net

2,671

2,814

2,830

2,704

2,444

2,304

2,056

1,763

1,488

1,366

1,254

1,163

988

757

592

428

367

384

398

415

438

470

498

506

478

442

418

419

470

-261

-846

-973

-1,040

-316

0

0

0

Net loss

-65,227

-55,489

-50,746

-48,774

-40,498

-37,966

12,474

16,804

14,438

17,859

-29,461

-29,973

-30,716

-39,963

-43,872

-48,447

-50,542

-47,305

-47,921

-47,215

-47,398

-46,929

-44,282

-42,774

-40,017

-38,673

-38,927

-39,610

-40,999

-39,891

-11,862

-10,404

-7,414

-4,617

0

0

0

Shares used to compute net (loss) income per common share
Basic and diluted net loss per common share

-0.35

-

-0.22

-0.26

-0.23

-

-0.22

-0.14

-0.19

-

-0.13

-0.19

-0.12

-

-0.15

-0.22

-0.34

-

-0.26

-0.28

-0.28

-0.28

-0.25

-0.28

-0.27

-0.22

-0.22

-0.23

-0.28

-0.27

-0.28

-0.30

-0.28

4.38

-2.06

-1.90

-1.52

Shares used to compute basic and diluted net loss per common share

61

-

58

58

52

-

50

49

48

-

48,602

48,224

48,115

-

47

45

44

-

44

43

43

-129,543

43,336

43,274

43,107

-120,623

42,839

41,337

36,611

36,348

36,180

36,169

32,931

-12,470

4,201

4,151

4,135